Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Gynecologic Oncology|December 6, 2001
Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53P T Ramirez, D M Gershenson, G Tortolero-Luna, et al.Gynecologic Oncology|November 7, 2000
Survey of female gynecologic oncologists and fellows: balancing professional and personal lifeM E Gordinier, L M Ramondetta, L P Parker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanismK R Brader, J K Wolf, M C Hung, et al.Gynecologic Oncology|September 14, 2000
Depression, anxiety, and quality of life in patients with epithelial ovarian cancerD Bodurka-Bevers, K Basen-Engquist, C L Carmack, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2006
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancerF C Maluf, A L Leiser, C Aghajanian, et al.Gynecologic Oncology|August 25, 2001
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancerM L Donato, D M Gershenson, J T Wharton, et al.Bone Marrow Transplantation|May 4, 2004
Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantationM L Donato, A Aleman, R E Champlin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trialG N Hortobagyi, N T Ueno, W Xia, et al.Pageof 3